2022 Q4 Form 20-F Financial Statement

#000149315224033941 Filed on August 27, 2024

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q1 2022
Revenue $593.6M
YoY Change -21.13%
Cost Of Revenue $53.26M
YoY Change -29.4%
Gross Profit $32.81M
YoY Change -23.11%
Gross Profit Margin 5.53%
Selling, General & Admin $84.75M
YoY Change -21.22%
% of Gross Profit 258.29%
Research & Development $326.5M
YoY Change 9.8%
% of Gross Profit 995.13%
Depreciation & Amortization $2.014M
YoY Change 22.21%
% of Gross Profit 6.14%
Operating Expenses $174.0M
YoY Change -6.28%
Operating Profit -$141.2M
YoY Change -1.26%
Interest Expense $62.00K
YoY Change 8.77%
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change -100.0%
Pretax Income -$976.2M
YoY Change 9.28%
Income Tax -$342.0K
% Of Pretax Income
Net Earnings -$974.9M
YoY Change 7.86%
Net Earnings / Revenue -164.23%
Basic Earnings Per Share -$3.03
Diluted Earnings Per Share -$3.03
COMMON SHARES
Basic Shares Outstanding 321.9M shares
Diluted Shares Outstanding 321.9M shares

Balance Sheet

Concept 2022 Q4 2022 Q1 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.855B
YoY Change -22.52%
Cash & Equivalents $526.7M
Short-Term Investments $1.328B
Other Short-Term Assets $81.29M
YoY Change -23.75%
Inventory
Prepaid Expenses
Receivables $184.5M
Other Receivables $105.0K $27.47M
Total Short-Term Assets $311.4M $2.148B
YoY Change -26.8% -20.77%
LONG-TERM ASSETS
Property, Plant & Equipment $14.39M $30.73M
YoY Change 2.09% 118.04%
Goodwill $54.43M
YoY Change -55.32%
Intangibles $2.455M
YoY Change -67.68%
Long-Term Investments $58.53M
YoY Change -54.18%
Other Assets $664.0K $4.580M
YoY Change 35.23% 46.42%
Total Long-Term Assets $23.95M $165.2M
YoY Change -51.57% -47.58%
TOTAL ASSETS
Total Short-Term Assets $311.4M $2.148B
Total Long-Term Assets $23.95M $165.2M
Total Assets $335.4M $2.313B
YoY Change -29.38% -23.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $17.71M $122.1M
YoY Change -23.77% -17.49%
Accrued Expenses $190.4M
YoY Change 120.29%
Deferred Revenue $359.8M
YoY Change 25.83%
Short-Term Debt $0.00
YoY Change -100.0%
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $107.9M $744.5M
YoY Change -1.84% 6.24%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change -100.0%
Other Long-Term Liabilities $132.0K $7.358M
YoY Change -74.76% 120.7%
Total Long-Term Liabilities $1.253M $7.358M
YoY Change -60.51% -35.1%
TOTAL LIABILITIES
Total Short-Term Liabilities $107.9M $744.5M
Total Long-Term Liabilities $1.253M $7.358M
Total Liabilities $109.2M $749.9M
YoY Change -3.48% 4.16%
SHAREHOLDERS EQUITY
Retained Earnings -$1.366B
YoY Change 3.06%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $17.53M
YoY Change 36.83%
Treasury Stock Shares
Shareholders Equity $226.6M $1.563B
YoY Change
Total Liabilities & Shareholders Equity $335.4M $2.313B
YoY Change -29.38% -23.57%

Cashflow Statement

Concept 2022 Q4 2022 Q1 2022
OPERATING ACTIVITIES
Net Income -$974.9M
YoY Change 7.86%
Depreciation, Depletion And Amortization $2.014M
YoY Change 22.21%
Cash From Operating Activities -$82.25M
YoY Change 120.15%
INVESTING ACTIVITIES
Capital Expenditures $845.0K
YoY Change -27.16%
Acquisitions
YoY Change
Other Investing Activities $358.4M
YoY Change -119.85%
Cash From Investing Activities $50.98M
YoY Change -117.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $1.161M
YoY Change
Cash From Financing Activities -$7.650M
YoY Change -101.99%
NET CHANGE
Cash From Operating Activities -$82.25M
Cash From Investing Activities $50.98M
Cash From Financing Activities -$7.650M
Net Change In Cash -$18.79M
YoY Change -133.65%
FREE CASH FLOW
Cash From Operating Activities -$82.25M
Capital Expenditures $845.0K
Free Cash Flow -$83.09M
YoY Change 115.71%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001804583
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
CY2022Q4 us-gaap Debt Current
DebtCurrent
CY2022Q4 us-gaap Debt Current
DebtCurrent
usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
CY2020 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
CY2020 RAASY Provision For Us Class Action
ProvisionForUSClassAction
CY2021 RAASY Provision For Us Class Action
ProvisionForUSClassAction
CY2020 us-gaap Other General Expense
OtherGeneralExpense
CY2022 RAASY Related Party Research And Development Expenses
RelatedPartyResearchAndDevelopmentExpenses
CY2021 us-gaap Investment Income Net
InvestmentIncomeNet
CY2020 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
CY2020 RAASY Gain From Disposal Of Longterm Investments
GainFromDisposalOfLongtermInvestments
CY2021 RAASY Gain From Disposal Of Longterm Investments
GainFromDisposalOfLongtermInvestments
CY2022 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
CY2022 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
usd
CY2020 RAASY Impairment Loss Of Other Investments
ImpairmentLossOfOtherInvestments
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
usd
CY2022 RAASY Temporary Equity Accretion To Redemption Values Adjustment
TemporaryEquityAccretionToRedemptionValuesAdjustment
CY2022 RAASY Temporary Equity Accretion To Redemption Values Adjustment
TemporaryEquityAccretionToRedemptionValuesAdjustment
usd
CY2021 RAASY Deemed Dividends To Preferred Shareholders
DeemedDividendsToPreferredShareholders
CY2022 RAASY Deemed Dividends To Preferred Shareholders
DeemedDividendsToPreferredShareholders
CY2022 RAASY Deemed Dividends To Preferred Shareholders
DeemedDividendsToPreferredShareholders
usd
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
CY2021 RAASY Pre Offering Ordinary Shares Converted To Ordinary Shares Value
PreOfferingOrdinarySharesConvertedToOrdinarySharesValue
CY2020 RAASY Amortization Of Rightofuse Asset And Interest On Lease Liabilities
AmortizationOfRightofuseAssetAndInterestOnLeaseLiabilities
CY2021 RAASY Amortization Of Rightofuse Asset And Interest On Lease Liabilities
AmortizationOfRightofuseAssetAndInterestOnLeaseLiabilities
CY2020 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
CY2022 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
CY2022 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
usd
CY2020 RAASY Gain From Disposal Of Longterm Investments
GainFromDisposalOfLongtermInvestments
CY2021 RAASY Gain From Disposal Of Longterm Investments
GainFromDisposalOfLongtermInvestments
CY2020 RAASY Impairment Loss On Long Term Investments
ImpairmentLossOnLongTermInvestments
CY2021 us-gaap Investment Income Net
InvestmentIncomeNet
CY2020 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
CY2020 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
CY2022 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
CY2022 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
usd
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
CY2021 RAASY Accretion Of Interest Expenses On Unsecured Loans
AccretionOfInterestExpensesOnUnsecuredLoans
CY2022 RAASY Accretion Of Interest Expenses On Unsecured Loans
AccretionOfInterestExpensesOnUnsecuredLoans
CY2022 RAASY Accretion Of Interest Expenses On Unsecured Loans
AccretionOfInterestExpensesOnUnsecuredLoans
usd
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
usd
CY2020 RAASY Provision For Us Class Action
ProvisionForUSClassAction
CY2021 RAASY Provision For Us Class Action
ProvisionForUSClassAction
CY2020 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
CY2020 RAASY Increase Decrease Operating Lease Rightofuse Assets
IncreaseDecreaseOperatingLeaseRightofuseAssets
CY2021 RAASY Increase Decrease Operating Lease Rightofuse Assets
IncreaseDecreaseOperatingLeaseRightofuseAssets
CY2020 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
CY2020 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
CY2020 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
CY2020 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
CY2022 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
CY2022 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
usd
CY2022 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
CY2022 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
usd
CY2021 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
CY2020 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
usd
CY2020 RAASY Cash Received From Consolidation Of Subsidiaries
CashReceivedFromConsolidationOfSubsidiaries
CY2022 RAASY Cash Received From Consolidation Of Subsidiaries
CashReceivedFromConsolidationOfSubsidiaries
CY2022 RAASY Cash Received From Consolidation Of Subsidiaries
CashReceivedFromConsolidationOfSubsidiaries
usd
CY2020 RAASY Cash Received From Disposal Of A Subsidiary
CashReceivedFromDisposalOfASubsidiary
CY2022 RAASY Cash Received From Disposal Of A Subsidiary
CashReceivedFromDisposalOfASubsidiary
CY2022 RAASY Cash Received From Disposal Of A Subsidiary
CashReceivedFromDisposalOfASubsidiary
usd
CY2020 us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
CY2022 us-gaap Cash Divested From Deconsolidation
CashDivestedFromDeconsolidation
CY2022 us-gaap Cash Divested From Deconsolidation
CashDivestedFromDeconsolidation
usd
CY2021 us-gaap Payments To Fund Longterm Loans To Related Parties
PaymentsToFundLongtermLoansToRelatedParties
CY2022 us-gaap Payments To Fund Longterm Loans To Related Parties
PaymentsToFundLongtermLoansToRelatedParties
CY2022 us-gaap Payments To Fund Longterm Loans To Related Parties
PaymentsToFundLongtermLoansToRelatedParties
usd
CY2022 us-gaap Proceeds From Collection Of Longterm Loans To Related Parties
ProceedsFromCollectionOfLongtermLoansToRelatedParties
CY2022 us-gaap Proceeds From Collection Of Longterm Loans To Related Parties
ProceedsFromCollectionOfLongtermLoansToRelatedParties
CY2020 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
CY2022 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
CY2022 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
usd
CY2021 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
CY2022 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
CY2022 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
usd
CY2020 RAASY Proceeds From Subscription Receivables For Redeemable Convertible Preferred Shares
ProceedsFromSubscriptionReceivablesForRedeemableConvertiblePreferredShares
CY2022 RAASY Proceeds From Subscription Receivables For Redeemable Convertible Preferred Shares
ProceedsFromSubscriptionReceivablesForRedeemableConvertiblePreferredShares
CY2022 RAASY Proceeds From Subscription Receivables For Redeemable Convertible Preferred Shares
ProceedsFromSubscriptionReceivablesForRedeemableConvertiblePreferredShares
usd
CY2020 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
CY2022 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
CY2022 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
usd
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
usd
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
usd
CY2021 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
CY2020 RAASY Payables To Variable Interest Entity Shareholder
PayablesToVariableInterestEntityShareholder
CY2022 RAASY Payables To Variable Interest Entity Shareholder
PayablesToVariableInterestEntityShareholder
CY2022 RAASY Payables To Variable Interest Entity Shareholder
PayablesToVariableInterestEntityShareholder
usd
CY2021 RAASY Cash Paid To Acquire Subsidiaries Equity Interests Held By Non Controlling Shareholders Net
CashPaidToAcquireSubsidiariesEquityInterestsHeldByNonControllingShareholdersNet
CY2022 RAASY Cash Paid To Acquire Subsidiaries Equity Interests Held By Non Controlling Shareholders Net
CashPaidToAcquireSubsidiariesEquityInterestsHeldByNonControllingShareholdersNet
CY2022 RAASY Cash Paid To Acquire Subsidiaries Equity Interests Held By Non Controlling Shareholders Net
CashPaidToAcquireSubsidiariesEquityInterestsHeldByNonControllingShareholdersNet
usd
CY2022 RAASY Payments Of Initial Public Offering Costs
PaymentsOfInitialPublicOfferingCosts
CY2022 RAASY Payments Of Initial Public Offering Costs
PaymentsOfInitialPublicOfferingCosts
usd
CY2020 us-gaap Payments For Repurchase Of Convertible Preferred Stock
PaymentsForRepurchaseOfConvertiblePreferredStock
CY2021 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
CY2022 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
CY2022 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
usd
CY2021 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
CY2022 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
CY2022 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
usd
CY2021 RAASY Transfer Of Equity Interest Of Subsidiaries
TransferOfEquityInterestOfSubsidiaries
CY2022 RAASY Transfer Of Equity Interest Of Subsidiaries
TransferOfEquityInterestOfSubsidiaries
CY2022 RAASY Transfer Of Equity Interest Of Subsidiaries
TransferOfEquityInterestOfSubsidiaries
usd
CY2022 RAASY Issuance Of Ordinary Shares As Consideration For Purchase Of Noncontrolling Interests
IssuanceOfOrdinarySharesAsConsiderationForPurchaseOfNoncontrollingInterests
CY2022 RAASY Issuance Of Ordinary Shares As Consideration For Purchase Of Noncontrolling Interests
IssuanceOfOrdinarySharesAsConsiderationForPurchaseOfNoncontrollingInterests
usd
CY2021 RAASY Accrual For Ipo Costs
AccrualForIpoCosts
CY2022 RAASY Accrual For Ipo Costs
AccrualForIpoCosts
CY2022 RAASY Accrual For Ipo Costs
AccrualForIpoCosts
usd
CY2021 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
CY2022 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
CY2022 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
usd
CY2021 RAASY Exercise Of Series E Warrant
ExerciseOfSeriesEWarrant
CY2022 RAASY Exercise Of Series E Warrant
ExerciseOfSeriesEWarrant
CY2022 RAASY Exercise Of Series E Warrant
ExerciseOfSeriesEWarrant
usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
CY2021Q4 RAASY Operating Lease Liabilities
OperatingLeaseLiabilities
CY2020Q4 us-gaap Goodwill
Goodwill
CY2021Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
CY2022Q4 RAASY Payable For Repurchase Of Treasury Stocks Current
PayableForRepurchaseOfTreasuryStocksCurrent
CY2021Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
CY2021Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
CY2021Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
CY2020 RAASY Fair Value Recurring Basis Short Term Investments Purchases Or Issuances
FairValueRecurringBasisShortTermInvestmentsPurchasesOrIssuances
CY2020 RAASY Reconciliation Recurring Basis Short Term Investments Gain Loss Included In Earnings
ReconciliationRecurringBasisShortTermInvestmentsGainLossIncludedInEarnings
CY2020 RAASY Fair Value Recurring Basis Short Term Investments Gain Loss Included In Other Comprehensive Income Loss
FairValueRecurringBasisShortTermInvestmentsGainLossIncludedInOtherComprehensiveIncomeLoss
CY2020 RAASY Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Short Term Investments
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentShortTermInvestments
CY2020Q4 RAASY Short Term Investments Fair Value Disclosure
ShortTermInvestmentsFairValueDisclosure
CY2019Q4 RAASY Warrant Liabilities Current At Fair Value Amount
WarrantLiabilitiesCurrentAtFairValueAmount
CY2020 RAASY Fair Value Recurring Basis Warrant Liabilities Current Portion Sales
FairValueRecurringBasisWarrantLiabilitiesCurrentPortionSales
CY2020 RAASY Fair Value Recurring Basis Non Current Portion Of Warrant Liabilities Purchasesorissuances
FairValueRecurringBasisNonCurrentPortionOfWarrantLiabilitiesPurchasesorissuances
CY2020Q4 RAASY Short Term Investments Fair Value Disclosure
ShortTermInvestmentsFairValueDisclosure
CY2021 RAASY Fair Value Recurring Basis Short Term Investments Sales
FairValueRecurringBasisShortTermInvestmentsSales
CY2021 RAASY Reconciliation Recurring Basis Short Term Investments Gain Loss Included In Earnings
ReconciliationRecurringBasisShortTermInvestmentsGainLossIncludedInEarnings
CY2021 RAASY Fair Value Recurring Basis Short Term Investments Gain Loss Included In Other Comprehensive Income Loss
FairValueRecurringBasisShortTermInvestmentsGainLossIncludedInOtherComprehensiveIncomeLoss
CY2021 RAASY Fair Value Recurring Basis Current Portion Of Warrant Liabilities Purchasesorissuances
FairValueRecurringBasisCurrentPortionOfWarrantLiabilitiesPurchasesorissuances
CY2021 RAASY Reconciliation Recurring Basis Current Portion Of Warrant Liabilities Gain Loss Included In Earnings
ReconciliationRecurringBasisCurrentPortionOfWarrantLiabilitiesGainLossIncludedInEarnings
CY2021Q4 RAASY Warrant Liabilities Current At Fair Value Amount
WarrantLiabilitiesCurrentAtFairValueAmount
CY2021 RAASY Fair Value Recurring Basis Non Current Portion Of Warrant Liabilities Purchasesorissuances
FairValueRecurringBasisNonCurrentPortionOfWarrantLiabilitiesPurchasesorissuances
CY2021Q4 RAASY Warrant Liabilities Noncurrent At Fair Value Amount
WarrantLiabilitiesNoncurrentAtFairValueAmount
CY2022 RAASY Reconciliation Recurring Basis Short Term Investments Gain Loss Included In Earnings
ReconciliationRecurringBasisShortTermInvestmentsGainLossIncludedInEarnings
CY2022 RAASY Fair Value Recurring Basis Short Term Investments Gain Loss Included In Other Comprehensive Income Loss
FairValueRecurringBasisShortTermInvestmentsGainLossIncludedInOtherComprehensiveIncomeLoss
CY2021 RAASY Effective Income Tax Rate Reconciliation Nondeductible Expense Uninvoiced Expenditures Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseUninvoicedExpendituresAmount
CY2022 RAASY Effective Income Tax Rate Reconciliation Nondeductible Expense Uninvoiced Expenditures Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseUninvoicedExpendituresAmount
CY2022 RAASY Income Tax Reconciliation Nondeductible Expense Initial Public Offering Fees
IncomeTaxReconciliationNondeductibleExpenseInitialPublicOfferingFees
CY2020 RAASY Effective Income Taxrate Reconciliation Non Deductible Expense Effect Of Withholding Tax On Interest Income Of Prc Subsidiary
EffectiveIncomeTaxrateReconciliationNonDeductibleExpenseEffectOfWithholdingTaxOnInterestIncomeOfPrcSubsidiary
CY2020 RAASY Effective Income Tax Reconciliation Effect Of Income Tax Rate Differences In Jurisdictions Other Than The Prc Amount
EffectiveIncomeTaxReconciliationEffectOfIncomeTaxRateDifferencesInJurisdictionsOtherThanThePrcAmount
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
CY2020Q4 RAASY Deferred Tax Liabilities Gain From Disposal Of Subsidiary
DeferredTaxLiabilitiesGainFromDisposalOfSubsidiary
CY2022 RAASY Valuation Allowance Deferred Tax Asset Decrease Upon Disposal Of Subsidiary Amount
ValuationAllowanceDeferredTaxAssetDecreaseUponDisposalOfSubsidiaryAmount
CY2022 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
CY2021Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
CY2022 dei Document Type
DocumentType
20-F
CY2022 dei Document Registration Statement
DocumentRegistrationStatement
false
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Document Shell Company Report
DocumentShellCompanyReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-40004
CY2022 dei Entity Registrant Name
EntityRegistrantName
Cloopen Group Holding Limited
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
16/F, Tower A, Fairmont Tower
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
33 Guangshun North Main Street
CY2022 dei Entity Address Address Line3
EntityAddressAddressLine3
Chaoyang District
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Beijing
CY2022 dei Entity Address Country
EntityAddressCountry
CN
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
CY2022 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2022 dei Document Accounting Standard
DocumentAccountingStandard
U.S. GAAP
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022 dei Auditor Firm
AuditorFirmId
3299
CY2022 dei Auditor Name
AuditorName
ARK PRO CPA & Co
CY2022 dei Auditor Location
AuditorLocation
Hong Kong, China
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
656179000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
526740000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
76370000 usd
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
698000
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
525000
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
76000 usd
CY2021Q4 RAASY Term Deposits
TermDeposits
1609864000
CY2022Q4 RAASY Term Deposits
TermDeposits
915845000
CY2022Q4 RAASY Term Deposits
TermDeposits
132785000 usd
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
127514000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
412031000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
59739000 usd
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
21118000
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
50838000
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
7371000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
136665000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
108129000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
15679000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
2711067000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
2147889000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
311416000 usd
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
127748000
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
58530000
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
8486000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14094000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14389000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2086000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16342000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2369000 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
48397000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
16934000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2455000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
121805000
CY2022Q4 us-gaap Goodwill
Goodwill
54427000
CY2022Q4 us-gaap Goodwill
Goodwill
7891000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3128000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4580000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
664000 usd
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
315172000
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
165202000
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
23951000 usd
CY2021Q4 us-gaap Assets
Assets
3026239000
CY2022Q4 us-gaap Assets
Assets
2313091000
CY2022Q4 us-gaap Assets
Assets
335367000 usd
CY2021Q4 us-gaap Debt Current
DebtCurrent
5500000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
148019000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
122124000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
17706000 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
285936000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
359801000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
52166000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10162000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1473000 usd
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
93511000
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
8915000
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
1293000 usd
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
166987000
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
242724000
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
35192000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
700747000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
744506000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
107943000 usd
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
8004000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6448000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
935000 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
8883000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1285000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
186000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3334000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
910000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
132000 usd
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
20221000
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
8643000
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1253000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
720968000
CY2022Q4 us-gaap Liabilities
Liabilities
753149000
CY2022Q4 us-gaap Liabilities
Liabilities
109196000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11066975000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11184360000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1621580000 usd
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
81638000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
120899000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
17529000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-232268000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-78613000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-11398000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8446942000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9421840000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1366038000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
2306336000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1563218000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
226646000 usd
CY2021Q4 us-gaap Minority Interest
MinorityInterest
-1065000
CY2022Q4 us-gaap Minority Interest
MinorityInterest
-3276000
CY2022Q4 us-gaap Minority Interest
MinorityInterest
-475000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2305271000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1559942000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
226171000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3026239000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2313091000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
335367000 usd
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
723453000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
752688000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
593634000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
86069000 usd
CY2020 us-gaap Cost Of Revenue
CostOfRevenue
478118000
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
480755000
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
367334000
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
53258000 usd
CY2020 us-gaap Gross Profit
GrossProfit
245335000
CY2021 us-gaap Gross Profit
GrossProfit
271933000
CY2022 us-gaap Gross Profit
GrossProfit
226300000
CY2022 us-gaap Gross Profit
GrossProfit
32811000 usd
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
200410000
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
300043000
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
265304000
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
38465000 usd
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
241356000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
385498000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
319217000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
46282000 usd
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
149092000
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
107407000
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
15573000 usd
CY2021 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
136000
CY2022 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
28011000
CY2022 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
4061000 usd
CY2022 RAASY Provision For Us Class Action
ProvisionForUSClassAction
83575000
CY2022 RAASY Provision For Us Class Action
ProvisionForUSClassAction
12117000 usd
CY2021 us-gaap Other General Expense
OtherGeneralExpense
51354000
CY2022 us-gaap Other General Expense
OtherGeneralExpense
70417000
CY2022 us-gaap Other General Expense
OtherGeneralExpense
10210000 usd
CY2020 RAASY Related Party Research And Development Expenses
RelatedPartyResearchAndDevelopmentExpenses
5667000
CY2021 RAASY Related Party Research And Development Expenses
RelatedPartyResearchAndDevelopmentExpenses
1974000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
174192000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
297360000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
326513000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
47340000 usd
CY2020 us-gaap Operating Expenses
OperatingExpenses
615958000
CY2021 us-gaap Operating Expenses
OperatingExpenses
1183483000
CY2022 us-gaap Operating Expenses
OperatingExpenses
1200444000
CY2022 us-gaap Operating Expenses
OperatingExpenses
174048000 usd
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-370623000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-911550000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-974144000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-141237000 usd
CY2020 us-gaap Interest Expense
InterestExpense
3477000
CY2021 us-gaap Interest Expense
InterestExpense
366000
CY2022 us-gaap Interest Expense
InterestExpense
428000
CY2022 us-gaap Interest Expense
InterestExpense
62000 usd
CY2020 us-gaap Interest Income Operating
InterestIncomeOperating
978000
CY2021 us-gaap Interest Income Operating
InterestIncomeOperating
11344000
CY2022 us-gaap Interest Income Operating
InterestIncomeOperating
14627000
CY2022 us-gaap Interest Income Operating
InterestIncomeOperating
2121000 usd
CY2020 us-gaap Investment Income Net
InvestmentIncomeNet
12000
CY2022 us-gaap Investment Income Net
InvestmentIncomeNet
340000
CY2022 us-gaap Investment Income Net
InvestmentIncomeNet
49000 usd
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-596000
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1969000
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-285000 usd
CY2022 RAASY Gain From Disposal Of Longterm Investments
GainFromDisposalOfLongtermInvestments
5138000
CY2022 RAASY Gain From Disposal Of Longterm Investments
GainFromDisposalOfLongtermInvestments
745000 usd
CY2020 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
11614000
CY2021 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
47247000
CY2021 RAASY Impairment Loss Of Other Investments
ImpairmentLossOfOtherInvestments
6603000
CY2022 RAASY Impairment Loss Of Other Investments
ImpairmentLossOfOtherInvestments
7400000
CY2022 RAASY Impairment Loss Of Other Investments
ImpairmentLossOfOtherInvestments
1073000 usd
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
61454000
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
29011000
CY2020 us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
-7275000
CY2021 us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
2899000
CY2022 us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
-2739000
CY2022 us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
-397000 usd
CY2020 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
6115000
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-6696000
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-9666000
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1401000 usd
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-424110000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-893332000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-976241000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-141540000 usd
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1127000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11120000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-342000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-50000 usd
CY2020 us-gaap Profit Loss
ProfitLoss
-425237000
CY2021 us-gaap Profit Loss
ProfitLoss
-904452000
CY2022 us-gaap Profit Loss
ProfitLoss
-975899000
CY2022 us-gaap Profit Loss
ProfitLoss
-141490000 usd
CY2020 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-5000
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-593000
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1001000
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-145000 usd
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-425232000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-903859000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-974898000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-141345000 usd
CY2020 RAASY Temporary Equity Accretion To Redemption Values Adjustment
TemporaryEquityAccretionToRedemptionValuesAdjustment
1139108000
CY2021 RAASY Temporary Equity Accretion To Redemption Values Adjustment
TemporaryEquityAccretionToRedemptionValuesAdjustment
4878652000
CY2020 RAASY Deemed Dividends To Preferred Shareholders
DeemedDividendsToPreferredShareholders
14729000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1579069000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5782511000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-974898000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-141345000 usd
CY2020 us-gaap Profit Loss
ProfitLoss
-425237000
CY2021 us-gaap Profit Loss
ProfitLoss
-904452000
CY2022 us-gaap Profit Loss
ProfitLoss
-975899000
CY2022 us-gaap Profit Loss
ProfitLoss
-141490000 usd
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
153151000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-308001000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
153655000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
22278000 usd
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
153151000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-308001000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
153655000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
22278000 usd
CY2020 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1425923000
CY2021 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-6091105000
CY2022 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-822244000
CY2022 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-119212000 usd
CY2020 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-81000
CY2021 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-593000
CY2022 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1001000
CY2022 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-145000 usd
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1425842000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6090512000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-821243000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-119067000 usd
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-18.55
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-18.55
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-19.62
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-19.62
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.03
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.03
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.44
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.44
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85103964 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85103964 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
294793258 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
294793258 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
321885046 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
321885046 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
321885046 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
321885046 shares
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1295090000
CY2020 RAASY Apic Share Based Payment Arrangement Increase For Cost Recognition Value
ApicShareBasedPaymentArrangementIncreaseForCostRecognitionValue
33139000
CY2020 RAASY Stock Issued During Period Value Purchase Of Non Controlling Interests Of Subsidiaries
StockIssuedDuringPeriodValuePurchaseOfNonControllingInterestsOfSubsidiaries
-19472000
CY2020 RAASY Reclassification Of Subscription Receivable To Other Current Assets
ReclassificationOfSubscriptionReceivableToOtherCurrentAssets
1000
CY2020 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
2893000
CY2020 us-gaap Profit Loss
ProfitLoss
-425237000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
101128000
CY2020 us-gaap Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
-1139108000
CY2020 RAASY Deemed Dividends To Preferred Shareholders
DeemedDividendsToPreferredShareholders
14729000
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
153151000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2603324000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2603324000
CY2021 RAASY Apic Share Based Payment Arrangement Increase For Cost Recognition Value
ApicShareBasedPaymentArrangementIncreaseForCostRecognitionValue
14754000
CY2021 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
8203436000
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2195827000
CY2021 RAASY Exercise Of Warrant Value
ExerciseOfWarrantValue
38844000
CY2021 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
340000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10968000
CY2021 RAASY Issuance Of Restrcited Ordinary Shares To Companys Interest Shareholders As Share Based Compensation Shares
IssuanceOfRestrcitedOrdinarySharesToCompanysInterestShareholdersAsShareBasedCompensationShares
89786000
CY2021 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
81638000
CY2021 RAASY Receive The Subscription Receivables For Series C And Series E Redeemable Convertible Preferred Shares
ReceiveTheSubscriptionReceivablesForSeriesCAndSeriesERedeemableConvertiblePreferredShares
336179000
CY2021 us-gaap Profit Loss
ProfitLoss
-904452000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
172188000
CY2021 us-gaap Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
-4878652000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-308001000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2305271000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2305271000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2305271000
CY2022 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
3667000
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4013000
CY2022 RAASY Issuance Of Restrcited Ordinary Shares To Companys Interest Shareholders As Share Based Compensation Shares
IssuanceOfRestrcitedOrdinarySharesToCompanysInterestShareholdersAsShareBasedCompensationShares
1034000
CY2022 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
39261000
CY2022 us-gaap Profit Loss
ProfitLoss
-975899000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
107462000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
153655000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1559942000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1559942000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
226171000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
226171000 usd
CY2020 us-gaap Profit Loss
ProfitLoss
-425237000
CY2021 us-gaap Profit Loss
ProfitLoss
-904452000
CY2022 us-gaap Profit Loss
ProfitLoss
-975899000
CY2022 us-gaap Profit Loss
ProfitLoss
-141490000 usd
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
34085000
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
17115000
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
25589000
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3710000 usd
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
134264000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
277617000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
107462000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
15581000 usd
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8616000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10504000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13893000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2014000 usd
CY2022 RAASY Amortization Of Rightofuse Asset And Interest On Lease Liabilities
AmortizationOfRightofuseAssetAndInterestOnLeaseLiabilities
8823000
CY2022 RAASY Amortization Of Rightofuse Asset And Interest On Lease Liabilities
AmortizationOfRightofuseAssetAndInterestOnLeaseLiabilities
1279000 usd
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-74000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
5122000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-8806000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1277000 usd
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-596000
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1969000
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-285000 usd
CY2020 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
11614000
CY2021 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
47247000
CY2022 RAASY Gain From Disposal Of Longterm Investments
GainFromDisposalOfLongtermInvestments
5138000
CY2022 RAASY Gain From Disposal Of Longterm Investments
GainFromDisposalOfLongtermInvestments
745000 usd
CY2021 RAASY Impairment Loss On Long Term Investments
ImpairmentLossOnLongTermInvestments
6603000
CY2022 RAASY Impairment Loss On Long Term Investments
ImpairmentLossOnLongTermInvestments
7400000
CY2022 RAASY Impairment Loss On Long Term Investments
ImpairmentLossOnLongTermInvestments
1073000 usd
CY2020 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
76000
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-493000
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-62000
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-9000 usd
CY2020 us-gaap Investment Income Net
InvestmentIncomeNet
12000
CY2022 us-gaap Investment Income Net
InvestmentIncomeNet
340000
CY2022 us-gaap Investment Income Net
InvestmentIncomeNet
49000 usd
CY2021 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
136000
CY2022 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
28011000
CY2022 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
4061000 usd
CY2021 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
24000
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
149092000
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
107407000
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
15573000 usd
CY2020 RAASY Accretion Of Interest Expenses On Unsecured Loans
AccretionOfInterestExpensesOnUnsecuredLoans
1894000
CY2020 us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
-7275000
CY2021 us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
2899000
CY2022 us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
-2739000
CY2022 us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
-397000 usd
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
61454000
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
29011000
CY2022 RAASY Provision For Us Class Action
ProvisionForUSClassAction
83575000
CY2022 RAASY Provision For Us Class Action
ProvisionForUSClassAction
12117000 usd
CY2020 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
6115000
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-6696000
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-9666000
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1401000 usd
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
52869000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-34342000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1234000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-179000 usd
CY2020 RAASY Increase Decrease In Accounts Receivable Related Parties Net
IncreaseDecreaseInAccountsReceivableRelatedPartiesNet
2989000
CY2021 RAASY Increase Decrease In Accounts Receivable Related Parties Net
IncreaseDecreaseInAccountsReceivableRelatedPartiesNet
-13420000
CY2022 RAASY Increase Decrease In Accounts Receivable Related Parties Net
IncreaseDecreaseInAccountsReceivableRelatedPartiesNet
-216000
CY2022 RAASY Increase Decrease In Accounts Receivable Related Parties Net
IncreaseDecreaseInAccountsReceivableRelatedPartiesNet
-31000 usd
CY2020 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
8498000
CY2021 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
6647000
CY2022 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
31422000
CY2022 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
4556000 usd
CY2021 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-3942000
CY2022 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
105000
CY2022 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
15000 usd
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
23484000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
15497000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-27591000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4000000 usd
CY2022 RAASY Increase Decrease Operating Lease Rightofuse Assets
IncreaseDecreaseOperatingLeaseRightofuseAssets
-25165000
CY2022 RAASY Increase Decrease Operating Lease Rightofuse Assets
IncreaseDecreaseOperatingLeaseRightofuseAssets
-3649000 usd
CY2020 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1089000
CY2021 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-1667000
CY2022 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1452000
CY2022 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
211000 usd
CY2020 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-4744000
CY2021 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
28206000
CY2022 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-24589000
CY2022 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-3565000 usd
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
55628000
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
94962000
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
61863000
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
8969000 usd
CY2020 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
522000
CY2021 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-3472000
CY2022 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-14000
CY2022 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-2000 usd
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
16610000
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
2408000 usd
CY2021 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
3334000
CY2022 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-2424000
CY2022 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-351000 usd
CY2020 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
16542000
CY2021 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
59253000
CY2022 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3974000
CY2022 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
578000 usd
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-216521000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-238079000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-567270000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-82245000 usd
CY2021 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
203164000
CY2022 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
116396000
CY2022 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
16876000 usd
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3402000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7390000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5825000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
845000 usd
CY2020 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
2667000
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1273000
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
980000
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
142000 usd
CY2021 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
21900000
CY2020 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
457000
CY2021 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
20000000
CY2020 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
2512000
CY2022 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
64833000
CY2022 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
9400000 usd
CY2021 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
127514000
CY2022 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
349350000
CY2022 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
50651000 usd
CY2020 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
62000
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
30000
CY2021 RAASY Cash Received From Consolidation Of Subsidiaries
CashReceivedFromConsolidationOfSubsidiaries
10890000
CY2021 RAASY Cash Received From Disposal Of A Subsidiary
CashReceivedFromDisposalOfASubsidiary
2500000
CY2021 us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
1500000
CY2022 us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
64987000
CY2022 us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
9422000 usd
CY2020 us-gaap Cash Divested From Deconsolidation
CashDivestedFromDeconsolidation
1471000
CY2021 us-gaap Cash Divested From Deconsolidation
CashDivestedFromDeconsolidation
1024000
CY2020 us-gaap Payments To Fund Longterm Loans To Related Parties
PaymentsToFundLongtermLoansToRelatedParties
3950000
CY2020 us-gaap Proceeds From Collection Of Longterm Loans To Related Parties
ProceedsFromCollectionOfLongtermLoansToRelatedParties
4160000
CY2021 us-gaap Proceeds From Collection Of Longterm Loans To Related Parties
ProceedsFromCollectionOfLongtermLoansToRelatedParties
2300000
CY2020 RAASY Payments For Term Deposits
PaymentsForTermDeposits
-160349000
CY2021 RAASY Payments For Term Deposits
PaymentsForTermDeposits
-3375933000
CY2022 RAASY Payments For Term Deposits
PaymentsForTermDeposits
-4345910000
CY2022 RAASY Payments For Term Deposits
PaymentsForTermDeposits
-630098000 usd
CY2020 us-gaap Proceeds From Payments For In Interest Bearing Deposits In Banks
ProceedsFromPaymentsForInInterestBearingDepositsInBanks
69762000
CY2021 us-gaap Proceeds From Payments For In Interest Bearing Deposits In Banks
ProceedsFromPaymentsForInInterestBearingDepositsInBanks
1926418000
CY2022 us-gaap Proceeds From Payments For In Interest Bearing Deposits In Banks
ProceedsFromPaymentsForInInterestBearingDepositsInBanks
5040269000
CY2022 us-gaap Proceeds From Payments For In Interest Bearing Deposits In Banks
ProceedsFromPaymentsForInInterestBearingDepositsInBanks
730770000 usd
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-95800000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1814560000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
351628000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
50980000 usd
CY2021 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
2195827000
CY2020 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
598662000
CY2021 RAASY Proceeds From Subscription Receivables For Redeemable Convertible Preferred Shares
ProceedsFromSubscriptionReceivablesForRedeemableConvertiblePreferredShares
336179000
CY2021 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
219667000
CY2020 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
6282000
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
5549000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
26892000
CY2020 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
106092000
CY2022 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
8004000
CY2022 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1161000 usd
CY2021 RAASY Payables To Variable Interest Entity Shareholder
PayablesToVariableInterestEntityShareholder
230087000
CY2020 RAASY Cash Paid To Acquire Subsidiaries Equity Interests Held By Non Controlling Shareholders Net
CashPaidToAcquireSubsidiariesEquityInterestsHeldByNonControllingShareholdersNet
16095000
CY2020 RAASY Payments Of Initial Public Offering Costs
PaymentsOfInitialPublicOfferingCosts
5714000
CY2021 RAASY Payments Of Initial Public Offering Costs
PaymentsOfInitialPublicOfferingCosts
8146000
CY2021 us-gaap Payments For Repurchase Of Convertible Preferred Stock
PaymentsForRepurchaseOfConvertiblePreferredStock
68894000
CY2022 us-gaap Payments For Repurchase Of Convertible Preferred Stock
PaymentsForRepurchaseOfConvertiblePreferredStock
39261000
CY2022 us-gaap Payments For Repurchase Of Convertible Preferred Stock
PaymentsForRepurchaseOfConvertiblePreferredStock
5692000 usd
CY2020 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
20000000
CY2020 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
26838000
CY2021 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
21140000
CY2022 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
5500000
CY2022 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
797000 usd
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
457641000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2444749000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-52765000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-7650000 usd
CY2020 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-10719000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-36235000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
138795000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20123000 usd
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
134601000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
355875000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-129612000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-18792000 usd
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
166401000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
301002000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
656877000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
95238000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
301002000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
656877000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
527265000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
76446000 usd
CY2020 us-gaap Interest Paid Net
InterestPaidNet
1608000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
291000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
479000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
69000 usd
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
116000
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
299000
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
368000
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
53000 usd
CY2020 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
33000
CY2020 RAASY Transfer Of Equity Interest Of Subsidiaries
TransferOfEquityInterestOfSubsidiaries
5793000
CY2020 RAASY Issuance Of Ordinary Shares As Consideration For Purchase Of Noncontrolling Interests
IssuanceOfOrdinarySharesAsConsiderationForPurchaseOfNoncontrollingInterests
27025000
CY2021 RAASY Issuance Of Ordinary Shares As Consideration For Purchase Of Noncontrolling Interests
IssuanceOfOrdinarySharesAsConsiderationForPurchaseOfNoncontrollingInterests
20621000
CY2020 RAASY Accrual For Ipo Costs
AccrualForIpoCosts
275000
CY2020 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
5549000
CY2020 RAASY Exercise Of Series E Warrant
ExerciseOfSeriesEWarrant
16550000
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84A_eus-gaap--UseOfEstimates_zSf2Elx00lw4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(c) <span id="xdx_86A_zRHcvHK0eGE2">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, related disclosures of contingent assets and liabilities at the balance sheet date, and the reported revenues and expenses during the reported period in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates, and as such, differences may be material to the consolidated financial statements. Significant accounting estimates reflected in the Group’s financial statements include, but not limited to, revenue recognition, fair value of assets and liabilities acquired in business combination, the allowance for doubtful accounts receivable and contract assets, depreciable lives and recoverability of property and equipment and intangible assets, assessment of impairment of long-lived assets, intangible assets and goodwill, the realization of deferred income tax assets, the fair value of share based compensation awards, redeemable convertible preferred shares, short-term investments, equity method investments, other equity investments, warrant liabilities, incremental borrowing rates for operating lease liabilities, the fair value of the ordinary shares to determine the existence of beneficial conversion feature of the redeemable convertible preferred shares, and management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2020, the World Health Organization declared the outbreak of a disease caused by a novel strain of the coronavirus (“COVID-19”) to be a pandemic. After the initial outbreak of the COVID-19, some instances of COVID-19 infections have emerged from time to time. The COVID-19 pandemic has created and may continue to create significant uncertainty in the macroeconomic environment which, in addition to other unforeseen effects of this pandemic, may adversely impact the Group’s results of operations. The extent to which COVID-19 would impacts the results of operations is contingent on the future developments of the outbreak, including constant updates concerning the global severity of and actions needed to contain the outbreak, which are highly uncertain and unpredictable. Due to the uncertainty and the economic implications on global economics conditions from the COVID-19 pandemic, certain estimates and assumptions may change in the near term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2022Q4 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
6.8972 pure
CY2021Q4 us-gaap Cash
Cash
28000
CY2022Q4 us-gaap Cash
Cash
23000
CY2021Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
656151000
CY2022Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
526717000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
656179000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
526740000
CY2021Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
24678000
CY2022Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
20337000
CY2021Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0044 pure
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0420 pure
CY2022 us-gaap Guarantees Indemnifications And Warranties Policies
GuaranteesIndemnificationsAndWarrantiesPolicies
<p id="xdx_846_eus-gaap--GuaranteesIndemnificationsAndWarrantiesPolicies_zRfVScLA2Zdc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(r) <span id="xdx_86C_ztg7S8NzB4zk">Warrant Liabilities</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The freestanding warrants to purchase redeemable convertible preferred shares at a future date were determined to be freestanding instruments that were accounted for as liabilities. At initial recognition, the Group recorded the warrant liabilities on the consolidated balance sheets at their estimated fair value and changes in estimated fair values were included in the change in fair value of warrant liabilities on the consolidated statement of comprehensive loss or allocated to the proceeds from the issuance of the debt instrument to the warrants based on the warrant liabilities fair value. The warrant liabilities are subject to remeasurement at each reporting period and the Group adjusted the carrying value of the warrant liabilities to fair value at the end of each reporting period utilizing the binominal option pricing model, with changes in estimated fair value included in the change in fair value of warrant liabilities on the consolidated statement of comprehensive loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
174192000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
297360000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
326513000
CY2020 us-gaap Advertising Expense
AdvertisingExpense
46942000
CY2021 us-gaap Advertising Expense
AdvertisingExpense
57618000
CY2022 us-gaap Advertising Expense
AdvertisingExpense
52716000
CY2020 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
45181000
CY2021 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
94148000
CY2022 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
104722000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
136665000
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
134002000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
34948000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
20405000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11882000
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84A_eus-gaap--ConcentrationRiskCreditRisk_zs4iDqnzJiSe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(dd) <span id="xdx_86E_z0TWRKVFWkx1">Concentration and Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Concentration of customers and suppliers</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--NumberOfCustomersAccountedForTenPercentOrMoreRevenue_do_uCUSTOMER_c20200101__20201231_zv9UuOcYuYne" title="Number of customers individually represent revenue"><span id="xdx_907_ecustom--NumberOfCustomersAccountedForTenPercentOrMoreRevenue_do_uCUSTOMER_c20210101__20211231_zSECkRDdgq6k" title="Number of customers individually represent revenue"><span id="xdx_909_ecustom--NumberOfCustomersAccountedForTenPercentOrMoreRevenue_do_uCUSTOMER_c20220101__20221231_zVLVOzBv2Ue6" title="Number of customers individually represent revenue">No</span></span></span> customers individually represent greater than 10.0% of total revenues of the Group during the years ended December 31, 2020, 2021 and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--NumberOfSuppliersAccountedForTenPercentOrMorePurchases_do_uSUPPLIER_c20200101__20201231_z5wR641RP331" title="Number of suppliers individually represent cost"><span id="xdx_904_ecustom--NumberOfSuppliersAccountedForTenPercentOrMorePurchases_do_uSUPPLIER_c20210101__20211231_zrO1XDveQH05" title="Number of suppliers individually represent cost">No</span></span> suppliers individually represent greater than 10.0% of total purchases of the Group during the years ended December 31, 2020 and 2021. <span id="xdx_901_ecustom--NumberOfSuppliersAccountedForTenPercentOrMorePurchases_dc_uSUPPLIER_c20220101__20221231_z7MVe7L16Lp5" title="Number of suppliers individually represent cost">One</span> supplier represents <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis__custom--SupplierOneMember_zsXoJJqfOpH8" title="Concentration risk percentage">11.1</span>% of total purchases of the Group during the year ended December 31,2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--NumberOfCustomersAccountedForTenPercentOrMoreAccountsReceivable_dc_uCUSTOMER_c20210101__20211231_znhLLlMcLIs9" title="Number of customers individually represent accounts receivable">One</span> customer represents <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zYgnrJdPil61" title="Concentration risk percentage">17.4</span>% of total accounts receivable, net including related party amounts and contract assets of the Group as of December 31, 2021. <span id="xdx_902_ecustom--NumberOfCustomersAccountedForTenPercentOrMoreAccountsReceivable_dc_uCUSTOMER_c20220101__20221231_z1brUsgK0sw8" title="Number of customers individually represent accounts receivable">Two</span> customers represent <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zzKMDeSANGSd" title="Concentration risk percentage">21.0</span>% and <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zS65tjHPuRr5" title="Concentration risk percentage">17.1</span>% of total accounts receivable, net including related party amounts and contract assets of the Group as of December 31, 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--NumberOfSuppliersAccountedForTenPercentOrMoreAccountsPayable_dc_uSUPPLIER_c20210101__20211231_zl3kEmTIJYVf" title="Number of suppliers individually represent accounts payable">Two</span> suppliers represent <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis__custom--SupplierOneMember_zeSWkQvrmU5j" title="Concentration risk percentage">12.7</span>% and <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis__custom--SupplierTwoMember_zRvncE8tcQD7" title="Concentration risk percentage">10.5</span>% of total accounts payable of the Group as of December 31, 2021, respectively. <span id="xdx_90E_ecustom--NumberOfSuppliersAccountedForTenPercentOrMoreAccountsPayable_dc_uSUPPLIER_c20220101__20221231_zXAHbVrPhlMa" title="Number of suppliers individually represent accounts payable">Two</span> suppliers represent <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis__custom--SupplierOneMember_z92oIqBI1pl3" title="Concentration risk percentage">11.2</span>% and <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis__custom--SupplierTwoMember_zfBIZohjJPHd" title="Concentration risk percentage">11.1</span>% of total accounts payable of the Group as of December 31, 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--NumberOfCustomersAccountedForTenPercentOrMoreContractLiabilities_dc_uCUSTOMER_c20210101__20211231_zF1ecz7wHVSk" title="Number of customers individually represent contract liabilities">One</span> customer represents <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--ContractLiabilitiesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zAq8YQ7TFl16" title="Concentration risk percentage">11.4</span>% of total contract liabilities of the Group as of December 31,2021, and <span id="xdx_90E_ecustom--NumberOfCustomersAccountedForTenPercentOrMoreContractLiabilities_dc_uCUSTOMER_c20220101__20221231_zo5IhDGvDIY4" title="Number of customers individually represent contract liabilities">no</span> customers individually represent greater than 10.0% of of total contract liabilities of the Group as of December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--NumberOfSuppliersAccountedForTenPercentOrMorePrepaymentsAndOtherCurrentAssetsExcludingRelatedPartyAmounts_dc_uSUPPLIER_c20210101__20211231_zcEJeWGfTh97" title="Number of supplier prepayments and other current assets">Two</span> suppliers represent <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--PrepaidExpensesAndOtherCurrentAssetsMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis__custom--SupplierOneMember_zaknf5W5YEW2" title="Concentration risk percentage">26.1</span>% and <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--PrepaidExpensesAndOtherCurrentAssetsMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis__custom--SupplierTwoMember_zZeJ5pZPKCsa" title="Concentration risk percentage">13.9</span>% of prepayments and other current assets excluding related party amounts of the Group as of December 31, 2021, respectively, and <span id="xdx_900_ecustom--NumberOfSuppliersAccountedForTenPercentOrMorePrepaymentsAndOtherCurrentAssetsExcludingRelatedPartyAmounts_dc_uSUPPLIER_c20220101__20221231_z6sayubDbg0h" title="Number of supplier prepayments and other current assets">one</span> supplier individually represents <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--PrepaidExpensesAndOtherCurrentAssetsMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis__custom--SupplierOneMember_zWy8G0BrqKhd" title="Concentration risk percentage">21.5</span>% of prepayments and other current assets excluding related party amounts of the Group as of December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Concentration of credit risk</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially expose the Group to concentrations of credit risk consist principally of cash, restricted cash, term deposits, short-term investments and accounts receivable. The total amount of these financial instruments was RMB<span id="xdx_902_ecustom--FinancialInstrumentsPotentiallyExposeToConcentrationsOfCreditRiskAmount_iI_pn6n6_c20211231_z2F5TCLxe1i3" title="Financial instruments amount">2,553</span> million and RMB<span id="xdx_90C_ecustom--FinancialInstrumentsPotentiallyExposeToConcentrationsOfCreditRiskAmount_iI_pn6n6_c20221231_zsmgn7K7e1Q6" title="Financial instruments amount">1,989</span> million as of December 31, 2021 and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group’s investment policy requires cash, restricted cash, term deposits and short-term investments to be placed with high-quality financial institutions and to limit the amount of credit risk from any one issuer. The Group regularly evaluates the credit standing of the counterparties or financial institutions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group conducts credit evaluations on its customers prior to delivery of goods or services. The assessment of customer creditworthiness is primarily based on historical collection records, research of publicly available information and customer on-site visits by senior management. Based on this analysis, the Group determines what credit terms, if any, to offer to each customer individually. If the assessment indicates a likelihood of collection risk, the Company will not deliver the services or sell the products to the customer or require the customer to pay cash, post letters of credit to secure payment or to make significant down payments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Interest rate risk</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group’s short-term bank borrowings bears interests at fixed rates. If the Group were to renew these loans, the Group might be subject to interest rate risk.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2020 RAASY Number Of Customers Accounted For Ten Percent Or More Revenue
NumberOfCustomersAccountedForTenPercentOrMoreRevenue
0 customer
CY2021 RAASY Number Of Customers Accounted For Ten Percent Or More Revenue
NumberOfCustomersAccountedForTenPercentOrMoreRevenue
0 customer
CY2022 RAASY Number Of Customers Accounted For Ten Percent Or More Revenue
NumberOfCustomersAccountedForTenPercentOrMoreRevenue
0 customer
CY2020 RAASY Number Of Suppliers Accounted For Ten Percent Or More Purchases
NumberOfSuppliersAccountedForTenPercentOrMorePurchases
0 supplier
CY2021 RAASY Number Of Suppliers Accounted For Ten Percent Or More Purchases
NumberOfSuppliersAccountedForTenPercentOrMorePurchases
0 supplier
CY2022 RAASY Number Of Suppliers Accounted For Ten Percent Or More Purchases
NumberOfSuppliersAccountedForTenPercentOrMorePurchases
1 supplier
CY2021 RAASY Number Of Customers Accounted For Ten Percent Or More Accounts Receivable
NumberOfCustomersAccountedForTenPercentOrMoreAccountsReceivable
1 customer
CY2022 RAASY Number Of Customers Accounted For Ten Percent Or More Accounts Receivable
NumberOfCustomersAccountedForTenPercentOrMoreAccountsReceivable
2 customer
CY2021 RAASY Number Of Suppliers Accounted For Ten Percent Or More Accounts Payable
NumberOfSuppliersAccountedForTenPercentOrMoreAccountsPayable
2 supplier
CY2022 RAASY Number Of Suppliers Accounted For Ten Percent Or More Accounts Payable
NumberOfSuppliersAccountedForTenPercentOrMoreAccountsPayable
2 supplier
CY2021 RAASY Number Of Customers Accounted For Ten Percent Or More Contract Liabilities
NumberOfCustomersAccountedForTenPercentOrMoreContractLiabilities
1 customer
CY2022 RAASY Number Of Customers Accounted For Ten Percent Or More Contract Liabilities
NumberOfCustomersAccountedForTenPercentOrMoreContractLiabilities
0 customer
CY2021 RAASY Number Of Suppliers Accounted For Ten Percent Or More Prepayments And Other Current Assets Excluding Related Party Amounts
NumberOfSuppliersAccountedForTenPercentOrMorePrepaymentsAndOtherCurrentAssetsExcludingRelatedPartyAmounts
2 supplier
CY2022 RAASY Number Of Suppliers Accounted For Ten Percent Or More Prepayments And Other Current Assets Excluding Related Party Amounts
NumberOfSuppliersAccountedForTenPercentOrMorePrepaymentsAndOtherCurrentAssetsExcludingRelatedPartyAmounts
1 supplier
CY2021Q4 RAASY Financial Instruments Potentially Expose To Concentrations Of Credit Risk Amount
FinancialInstrumentsPotentiallyExposeToConcentrationsOfCreditRiskAmount
2553000000
CY2022Q4 RAASY Financial Instruments Potentially Expose To Concentrations Of Credit Risk Amount
FinancialInstrumentsPotentiallyExposeToConcentrationsOfCreditRiskAmount
1989000000
CY2021Q4 us-gaap Statutory Accounting Practices Retained Earnings Not Available For Dividends
StatutoryAccountingPracticesRetainedEarningsNotAvailableForDividends
0
CY2022Q4 us-gaap Statutory Accounting Practices Retained Earnings Not Available For Dividends
StatutoryAccountingPracticesRetainedEarningsNotAvailableForDividends
0
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
656179000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
526740000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
698000
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
525000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
656877000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
527265000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
43104000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
57344000
CY2021 RAASY Accounts Receivable Allowance For Credit Loss Additions Charged To Reversal Of Bad Debt Expense
AccountsReceivableAllowanceForCreditLossAdditionsChargedToReversalOfBadDebtExpense
14526000
CY2022 RAASY Accounts Receivable Allowance For Credit Loss Additions Charged To Reversal Of Bad Debt Expense
AccountsReceivableAllowanceForCreditLossAdditionsChargedToReversalOfBadDebtExpense
23898000
CY2021 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
286000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
57344000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
81242000
CY2020Q4 RAASY Accounts Receivable Related Parties Allowance For Credit Loss Current
AccountsReceivableRelatedPartiesAllowanceForCreditLossCurrent
1298000
CY2021Q4 RAASY Accounts Receivable Related Parties Allowance For Credit Loss Current
AccountsReceivableRelatedPartiesAllowanceForCreditLossCurrent
16000
CY2021 RAASY Additions Charged To Reversal Of Bad Debt Expense Related Parties
AdditionsChargedToReversalOfBadDebtExpenseRelatedParties
-1282000
CY2022 RAASY Additions Charged To Reversal Of Bad Debt Expense Related Parties
AdditionsChargedToReversalOfBadDebtExpenseRelatedParties
-11000
CY2021Q4 RAASY Accounts Receivable Related Parties Allowance For Credit Loss Current
AccountsReceivableRelatedPartiesAllowanceForCreditLossCurrent
16000
CY2022Q4 RAASY Accounts Receivable Related Parties Allowance For Credit Loss Current
AccountsReceivableRelatedPartiesAllowanceForCreditLossCurrent
5000
CY2021Q4 RAASY Allowance For Doubtful Accounts Receivable Within One Year
AllowanceForDoubtfulAccountsReceivableWithinOneYear
8354000
CY2022Q4 RAASY Allowance For Doubtful Accounts Receivable Within One Year
AllowanceForDoubtfulAccountsReceivableWithinOneYear
7031000
CY2021Q4 RAASY Allowance For Doubtful Accounts Receivable Thereafter
AllowanceForDoubtfulAccountsReceivableThereafter
48990000
CY2022Q4 RAASY Allowance For Doubtful Accounts Receivable Thereafter
AllowanceForDoubtfulAccountsReceivableThereafter
74211000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
57344000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
81242000
CY2021Q4 RAASY Accounts Receivable Related Parties Allowance For Credit Loss Current Within One Year
AccountsReceivableRelatedPartiesAllowanceForCreditLossCurrentWithinOneYear
16000
CY2022Q4 RAASY Accounts Receivable Related Parties Allowance For Credit Loss Current Within One Year
AccountsReceivableRelatedPartiesAllowanceForCreditLossCurrentWithinOneYear
5000
CY2021Q4 RAASY Accounts Receivable Related Parties Allowance For Credit Loss Current
AccountsReceivableRelatedPartiesAllowanceForCreditLossCurrent
16000
CY2022Q4 RAASY Accounts Receivable Related Parties Allowance For Credit Loss Current
AccountsReceivableRelatedPartiesAllowanceForCreditLossCurrent
5000
CY2021Q4 us-gaap Supplies
Supplies
82482000
CY2022Q4 us-gaap Supplies
Supplies
60721000
CY2021Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
15798000
CY2022Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
11417000
CY2021Q4 RAASY Staff Advances
StaffAdvances
938000
CY2022Q4 RAASY Staff Advances
StaffAdvances
902000
CY2021Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
20391000
CY2022Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
25975000
CY2021Q4 RAASY Receivable From Third Party Payment Platforms Current
ReceivableFromThirdPartyPaymentPlatformsCurrent
10364000
CY2022Q4 RAASY Receivable From Third Party Payment Platforms Current
ReceivableFromThirdPartyPaymentPlatformsCurrent
1387000
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
6692000
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
7727000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
136665000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
108129000
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
127748000
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
58530000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
29636000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
34882000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
15542000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20493000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14094000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14389000
CY2020 us-gaap Depreciation
Depreciation
4721000
CY2021 us-gaap Depreciation
Depreciation
5507000
CY2022 us-gaap Depreciation
Depreciation
5304000
CY2020 us-gaap Depreciation
Depreciation
4721000
CY2021 us-gaap Depreciation
Depreciation
5507000
CY2022 us-gaap Depreciation
Depreciation
5304000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16342000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10162000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6448000
CY2022Q4 RAASY Operating Lease Liabilities
OperatingLeaseLiabilities
16610000
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
24158000
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
3503000 usd
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
1414000
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
205000 usd
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
2315000
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
336000 usd
CY2022 us-gaap Lease Cost
LeaseCost
27887000
CY2022 us-gaap Lease Cost
LeaseCost
4044000 usd
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y8M26D
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0528 pure
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
27575000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
3998000 usd
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
7455000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1081000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
13260000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1923000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
6031000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
874000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
941000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
136000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
20232000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2933000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2895000
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
420000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
17337000
CY2022Q4 RAASY Operating Lease Liability Balance
OperatingLeaseLiabilityBalance
2513000 usd
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
26263000
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
9615000
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
2806000
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
20976000
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
23738000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
61695000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-13162000
CY2021 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
136000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
48397000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
66793000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
21711000
CY2022Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
28148000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
16934000
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3895
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4997
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8589
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
3447000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2977000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2360000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2227000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1900000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
4021000
CY2021 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
270897000
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
149092000
CY2021Q4 us-gaap Goodwill
Goodwill
121805000
CY2022 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
40029000
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
107407000
CY2022Q4 us-gaap Goodwill
Goodwill
54427000
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
149100000
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
107400000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
8004000
CY2021Q4 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.0545 pure
CY2021Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
82993000
CY2022Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
95297000
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
19241000
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
21742000
CY2021Q4 RAASY Payable For Repurchase Of Treasury Stocks Current
PayableForRepurchaseOfTreasuryStocksCurrent
12744000
CY2021Q4 RAASY Deposits Of Depositary Bank Current
DepositsOfDepositaryBankCurrent
30641000
CY2022Q4 RAASY Deposits Of Depositary Bank Current
DepositsOfDepositaryBankCurrent
32726000
CY2021Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
191000
CY2022Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
303000
CY2021Q4 RAASY Staff Reimbursements Current
StaffReimbursementsCurrent
17918000
CY2022Q4 RAASY Staff Reimbursements Current
StaffReimbursementsCurrent
7991000
CY2022Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
83575000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3259000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1090000
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
166987000
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
242724000
CY2020Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3706745 shares
CY2020Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3501087 shares
CY2019Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
1424129000
CY2020 RAASY Temporary Equity Stock Issued During Period Value New Issues Warrants Exercise
TemporaryEquityStockIssuedDuringPeriodValueNewIssuesWarrantsExercise
122642000
CY2020 RAASY Temporary Equity Stock Issued During Period Value New Issues Cash
TemporaryEquityStockIssuedDuringPeriodValueNewIssuesCash
598662000
CY2020 RAASY Temporary Equity Stock Issued During Period Value New Issues Issuance Costs
TemporaryEquityStockIssuedDuringPeriodValueNewIssuesIssuanceCosts
-11830000
CY2020 RAASY Temporary Equity Stock Issued During Period Value Deemed Dividends
TemporaryEquityStockIssuedDuringPeriodValueDeemedDividends
14729000
CY2020 RAASY Temporary Equity Accretion To Redemption Value Adjustments
TemporaryEquityAccretionToRedemptionValueAdjustments
1139108000
CY2020 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-161860000
CY2020Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
3125580000
CY2020 RAASY Temporary Equity Subscriptions Receivables
TemporaryEquitySubscriptionsReceivables
-336179000
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
2789401000
CY2021Q1 us-gaap Temporary Equity Stock Issued During Period Value New Issues
TemporaryEquityStockIssuedDuringPeriodValueNewIssues
257198000
CY2021Q1 RAASY Temporary Equity Accretion To Redemption Value Adjustments
TemporaryEquityAccretionToRedemptionValueAdjustments
4878653000
CY2021Q1 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
278182000
CY2021Q1 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
8203434000
CY2021Q1 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
8203434000
us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
-8203434000
CY2022 RAASY Temporary Equity Redemption Percentage Of Issue Price
TemporaryEquityRedemptionPercentageOfIssuePrice
1 pure
CY2022 RAASY Temporary Equity Redemption Percentage Of Compound Per Annum
TemporaryEquityRedemptionPercentageOfCompoundPerAnnum
0.08 pure
CY2022 RAASY Temporary Equity Dividend Percent
TemporaryEquityDividendPercent
0.08 pure
CY2022 RAASY Temporary Equity Liquidation Preference Percentage
TemporaryEquityLiquidationPreferencePercentage
1 pure
CY2022 RAASY Temporary Equity Redemption Percentage Of Compound Per Annum
TemporaryEquityRedemptionPercentageOfCompoundPerAnnum
0.08 pure
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.24
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.19
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
10284000
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y8M12D
CY2019Q4 RAASY Short Term Investments Fair Value Disclosure
ShortTermInvestmentsFairValueDisclosure
2501000
CY2020 RAASY Fair Value Recurring Basis Short Term Investments Sales
FairValueRecurringBasisShortTermInvestmentsSales
2501000
CY2020 RAASY Fair Value Recurring Basis Current Portion Of Warrant Liabilities Purchasesorissuances
FairValueRecurringBasisCurrentPortionOfWarrantLiabilitiesPurchasesorissuances
21622000
CY2020 RAASY Reconciliation Recurring Basis Current Portion Of Warrant Liabilities Gain Loss Included In Earnings
ReconciliationRecurringBasisCurrentPortionOfWarrantLiabilitiesGainLossIncludedInEarnings
16906000
CY2020 RAASY Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Warrant Liabilities Current Portion
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentWarrantLiabilitiesCurrentPortion
415000
CY2020Q4 RAASY Warrant Liabilities Current At Fair Value Amount
WarrantLiabilitiesCurrentAtFairValueAmount
37903000
CY2019Q4 RAASY Warrant Liabilities Noncurrent At Fair Value Amount
WarrantLiabilitiesNoncurrentAtFairValueAmount
4709000
CY2020 RAASY Fair Value Recurring Basis Warrant Liabilities Non Current Portion Sales
FairValueRecurringBasisWarrantLiabilitiesNonCurrentPortionSales
16550000
CY2020 RAASY Reconciliation Recurring Basis Non Current Portion Of Warrant Liabilities Gain Loss Included In Earnings
ReconciliationRecurringBasisNonCurrentPortionOfWarrantLiabilitiesGainLossIncludedInEarnings
23376000
CY2020 RAASY Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Warrant Liabilities Non Current Portion
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentWarrantLiabilitiesNonCurrentPortion
1885000
CY2020Q4 RAASY Warrant Liabilities Noncurrent At Fair Value Amount
WarrantLiabilitiesNoncurrentAtFairValueAmount
9650000
CY2021 RAASY Fair Value Recurring Basis Short Term Investments Purchases Or Issuances
FairValueRecurringBasisShortTermInvestmentsPurchasesOrIssuances
127727000
CY2021 RAASY Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Short Term Investments
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentShortTermInvestments
213000
CY2021Q4 RAASY Short Term Investments Fair Value Disclosure
ShortTermInvestmentsFairValueDisclosure
127514000
CY2020Q4 RAASY Warrant Liabilities Current At Fair Value Amount
WarrantLiabilitiesCurrentAtFairValueAmount
37903000
CY2021 RAASY Fair Value Recurring Basis Warrant Liabilities Current Portion Sales
FairValueRecurringBasisWarrantLiabilitiesCurrentPortionSales
37531000
CY2021 RAASY Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Warrant Liabilities Current Portion
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentWarrantLiabilitiesCurrentPortion
372000
CY2020Q4 RAASY Warrant Liabilities Noncurrent At Fair Value Amount
WarrantLiabilitiesNoncurrentAtFairValueAmount
9650000
CY2021 RAASY Fair Value Recurring Basis Warrant Liabilities Non Current Portion Sales
FairValueRecurringBasisWarrantLiabilitiesNonCurrentPortionSales
38841000
CY2021 RAASY Reconciliation Recurring Basis Non Current Portion Of Warrant Liabilities Gain Loss Included In Earnings
ReconciliationRecurringBasisNonCurrentPortionOfWarrantLiabilitiesGainLossIncludedInEarnings
29011000
CY2021 RAASY Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Warrant Liabilities Non Current Portion
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentWarrantLiabilitiesNonCurrentPortion
-180000
CY2021Q4 RAASY Short Term Investments Fair Value Disclosure
ShortTermInvestmentsFairValueDisclosure
127514000
CY2022 RAASY Fair Value Recurring Basis Short Term Investments Purchases Or Issuances
FairValueRecurringBasisShortTermInvestmentsPurchasesOrIssuances
357142000
CY2022 RAASY Fair Value Recurring Basis Short Term Investments Sales
FairValueRecurringBasisShortTermInvestmentsSales
70306000
CY2022 RAASY Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Short Term Investments
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentShortTermInvestments
2320000
CY2022Q4 RAASY Short Term Investments Fair Value Disclosure
ShortTermInvestmentsFairValueDisclosure
412031000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-424110000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-893332000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-976241000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1201000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
5998000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
8464000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-74000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
5122000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-8806000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1127000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11120000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-342000
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-106028000
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-223333000
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-244060000
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
33566000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
66705000
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
26865000
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense Meals And Entertainment
IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment
577000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Meals And Entertainment
IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment
940000
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Meals And Entertainment
IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment
1240000
CY2020 RAASY Effective Income Tax Rate Reconciliation Nondeductible Expense Uninvoiced Expenditures Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseUninvoicedExpendituresAmount
217000
CY2020 RAASY Effective Income Tax Rate Reconciliation Nondeductible Expense Taxable Deemed Interest Income From Inter Company Interest Free Loans Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTaxableDeemedInterestIncomeFromInterCompanyInterestFreeLoansAmount
2155000
CY2021 RAASY Effective Income Tax Rate Reconciliation Nondeductible Expense Taxable Deemed Interest Income From Inter Company Interest Free Loans Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTaxableDeemedInterestIncomeFromInterCompanyInterestFreeLoansAmount
6659000
CY2022 RAASY Effective Income Tax Rate Reconciliation Nondeductible Expense Taxable Deemed Interest Income From Inter Company Interest Free Loans Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTaxableDeemedInterestIncomeFromInterCompanyInterestFreeLoansAmount
2659000
CY2020 RAASY Income Tax Reconciliation Nondeductible Expense Initial Public Offering Fees
IncomeTaxReconciliationNondeductibleExpenseInitialPublicOfferingFees
2210000
CY2021 RAASY Income Tax Reconciliation Nondeductible Expense Initial Public Offering Fees
IncomeTaxReconciliationNondeductibleExpenseInitialPublicOfferingFees
824000
CY2020 RAASY Effective Income Tax Reconciliation Employee Commercial Insurance Amount
EffectiveIncomeTaxReconciliationEmployeeCommercialInsuranceAmount
110000
CY2021 RAASY Effective Income Tax Reconciliation Employee Commercial Insurance Amount
EffectiveIncomeTaxReconciliationEmployeeCommercialInsuranceAmount
372000
CY2022 RAASY Effective Income Tax Reconciliation Employee Commercial Insurance Amount
EffectiveIncomeTaxReconciliationEmployeeCommercialInsuranceAmount
291000
CY2022 RAASY Effective Income Tax Rate Reconciliation Non Deductible Expense Effect Of Withholding Tax On Interest Income Of Subsidiary Percent
EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseEffectOfWithholdingTaxOnInterestIncomeOfSubsidiaryPercent
0.07 pure
CY2021 RAASY Effective Income Taxrate Reconciliation Non Deductible Expense Effect Of Withholding Tax On Interest Income Of Prc Subsidiary
EffectiveIncomeTaxrateReconciliationNonDeductibleExpenseEffectOfWithholdingTaxOnInterestIncomeOfPrcSubsidiary
1144000
CY2022 RAASY Effective Income Taxrate Reconciliation Non Deductible Expense Effect Of Withholding Tax On Interest Income Of Prc Subsidiary
EffectiveIncomeTaxrateReconciliationNonDeductibleExpenseEffectOfWithholdingTaxOnInterestIncomeOfPrcSubsidiary
2121000
CY2020 RAASY Effective Income Tax Reconciliation Selling Commission Amount
EffectiveIncomeTaxReconciliationSellingCommissionAmount
581000
CY2021 RAASY Effective Income Tax Reconciliation Selling Commission Amount
EffectiveIncomeTaxReconciliationSellingCommissionAmount
2072000
CY2022 RAASY Effective Income Tax Reconciliation Selling Commission Amount
EffectiveIncomeTaxReconciliationSellingCommissionAmount
1003000
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
46000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
63000
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
109000
CY2020 RAASY Effective Income Tax Reconciliation Non Prc Entities Not Subject To Income Tax Amount
EffectiveIncomeTaxReconciliationNonPrcEntitiesNotSubjectToIncomeTaxAmount
7296000
CY2021 RAASY Effective Income Tax Reconciliation Non Prc Entities Not Subject To Income Tax Amount
EffectiveIncomeTaxReconciliationNonPrcEntitiesNotSubjectToIncomeTaxAmount
47479000
CY2022 RAASY Effective Income Tax Reconciliation Non Prc Entities Not Subject To Income Tax Amount
EffectiveIncomeTaxReconciliationNonPrcEntitiesNotSubjectToIncomeTaxAmount
66530000
CY2021 RAASY Effective Income Tax Reconciliation Effect Of Income Tax Rate Differences In Jurisdictions Other Than The Prc Amount
EffectiveIncomeTaxReconciliationEffectOfIncomeTaxRateDifferencesInJurisdictionsOtherThanThePrcAmount
-2334000
CY2022 RAASY Effective Income Tax Reconciliation Effect Of Income Tax Rate Differences In Jurisdictions Other Than The Prc Amount
EffectiveIncomeTaxReconciliationEffectOfIncomeTaxRateDifferencesInJurisdictionsOtherThanThePrcAmount
2964000
CY2020 RAASY Effective Income Tax Rate Reconciliation Nondeductible Expense Prior Year Over Provision Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpensePriorYearOverProvisionAmount
104000
CY2021 RAASY Effective Income Tax Rate Reconciliation Nondeductible Expense Prior Year Over Provision Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpensePriorYearOverProvisionAmount
4883000
CY2022 RAASY Effective Income Tax Rate Reconciliation Nondeductible Expense Prior Year Over Provision Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpensePriorYearOverProvisionAmount
203000
CY2020 RAASY Effective Income Tax Reconciliation Net Operating Loss Expired Amount
EffectiveIncomeTaxReconciliationNetOperatingLossExpiredAmount
200000
CY2021 RAASY Effective Income Tax Reconciliation Net Operating Loss Expired Amount
EffectiveIncomeTaxReconciliationNetOperatingLossExpiredAmount
8635000
CY2022 RAASY Effective Income Tax Reconciliation Net Operating Loss Expired Amount
EffectiveIncomeTaxReconciliationNetOperatingLossExpiredAmount
38871000
CY2020 RAASY Effective Income Tax Reconciliation Amortization Of Intangible Assets Formed By Business Combinations Amount
EffectiveIncomeTaxReconciliationAmortizationOfIntangibleAssetsFormedByBusinessCombinationsAmount
-74000
CY2021 RAASY Effective Income Tax Reconciliation Amortization Of Intangible Assets Formed By Business Combinations Amount
EffectiveIncomeTaxReconciliationAmortizationOfIntangibleAssetsFormedByBusinessCombinationsAmount
-536000
CY2022 RAASY Effective Income Tax Reconciliation Amortization Of Intangible Assets Formed By Business Combinations Amount
EffectiveIncomeTaxReconciliationAmortizationOfIntangibleAssetsFormedByBusinessCombinationsAmount
-8806000
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
813000
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
1701000
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
60167000
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
96734000
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
107967000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1127000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11120000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-342000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
218478000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
280865000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
349681000
CY2020Q4 RAASY Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Uninvoiced Expenditures
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUninvoicedExpenditures
6204000
CY2021Q4 RAASY Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Uninvoiced Expenditures
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUninvoicedExpenditures
9867000
CY2022Q4 RAASY Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Uninvoiced Expenditures
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUninvoicedExpenditures
9867000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
12707000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
16486000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
22172000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses
10337000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses
11412000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses
12777000
CY2020Q4 RAASY Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Goodwill Impairment
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsGoodwillImpairment
1417000
CY2021Q4 RAASY Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Goodwill Impairment
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsGoodwillImpairment
38690000
CY2022Q4 RAASY Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Goodwill Impairment
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsGoodwillImpairment
55534000
CY2020Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
174000
CY2021Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
149000
CY2022Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
641000
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
9000
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2050000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
239007000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
335339000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
443306000
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
10319000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
22131000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
9416000
CY2020Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
185000
CY2021Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
8883000
CY2022Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
1285000
CY2021Q4 RAASY Deferred Tax Liabilities Gain From Disposal Of Subsidiary
DeferredTaxLiabilitiesGainFromDisposalOfSubsidiary
-2766000
CY2022Q4 RAASY Deferred Tax Liabilities Gain From Disposal Of Subsidiary
DeferredTaxLiabilitiesGainFromDisposalOfSubsidiary
-2766000
CY2020Q4 us-gaap Deferred Tax Liabilities Investments
DeferredTaxLiabilitiesInvestments
10319000
CY2021Q4 us-gaap Deferred Tax Liabilities Investments
DeferredTaxLiabilitiesInvestments
19365000
CY2022Q4 us-gaap Deferred Tax Liabilities Investments
DeferredTaxLiabilitiesInvestments
6650000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
10504000
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
31014000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
10701000
CY2020Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
185000
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
8883000
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1285000
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1598000000
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1598037000
CY2022Q4 RAASY Operating Loss Carryforwards Expiration Year One
OperatingLossCarryforwardsExpirationYearOne
134456000
CY2022Q4 RAASY Operating Loss Carryforwards Expiration Year Two
OperatingLossCarryforwardsExpirationYearTwo
49989000
CY2022Q4 RAASY Operating Loss Carryforwards Expiration Year Three
OperatingLossCarryforwardsExpirationYearThree
76725000
CY2022Q4 RAASY Operating Loss Carryforwards Expiration Year Four
OperatingLossCarryforwardsExpirationYearFour
268086000
CY2022Q4 RAASY Operating Loss Carryforwards Expiration Year Five
OperatingLossCarryforwardsExpirationYearFive
288277000
CY2022Q4 RAASY Operating Loss Carryforwards Expiration Year Five And After
OperatingLossCarryforwardsExpirationYearFiveAndAfter
780504000
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1598037000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
180643000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
239007000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
335339000
CY2020 RAASY Valuation Allowance Deferred Tax Asset Increase Amount
ValuationAllowanceDeferredTaxAssetIncreaseAmount
-60167000
CY2021 RAASY Valuation Allowance Deferred Tax Asset Increase Amount
ValuationAllowanceDeferredTaxAssetIncreaseAmount
-96734000
CY2022 RAASY Valuation Allowance Deferred Tax Asset Increase Amount
ValuationAllowanceDeferredTaxAssetIncreaseAmount
-107967000
CY2020 RAASY Valuation Allowance Deferred Tax Asset Decrease Upon Disposal Of Subsidiary Amount
ValuationAllowanceDeferredTaxAssetDecreaseUponDisposalOfSubsidiaryAmount
1803000
CY2021 RAASY Valuation Allowance Deferred Tax Asset Decrease Upon Disposal Of Subsidiary Amount
ValuationAllowanceDeferredTaxAssetDecreaseUponDisposalOfSubsidiaryAmount
402000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
239007000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
335339000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
443306000
CY2022 RAASY Statute Limitation Period
StatuteLimitationPeriod
P5Y
CY2022 RAASY Underpayment Of Taxes Special Circumstances
UnderpaymentOfTaxesSpecialCircumstances
100000
CY2021 RAASY Statute Limitation Period
StatuteLimitationPeriod
P10Y
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-903859000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-974898000
CY2021 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
-4878652000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5782511000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-974898000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
294793258 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
321885046 shares
CY2021 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
294793258000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
321885046000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-19.62
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-19.62
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.03
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.03
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
723453000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
752688000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
593634000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
723453000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
752688000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
593634000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
723453000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
752688000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
593634000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
723453000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
752688000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
593634000
CY2020Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
18342000
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
21118000
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
50838000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
177376000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
285936000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
359801000
CY2019Q4 us-gaap Contract With Customer Asset Gross Current
ContractWithCustomerAssetGrossCurrent
16577000
CY2020Q4 us-gaap Contract With Customer Asset Gross Current
ContractWithCustomerAssetGrossCurrent
25075000
CY2021Q4 us-gaap Contract With Customer Asset Gross Current
ContractWithCustomerAssetGrossCurrent
31722000
CY2020 RAASY Revenue Recognized Increase In Contract Assets
RevenueRecognizedIncreaseInContractAssets
46662000
CY2021 RAASY Revenue Recognized Increase In Contract Assets
RevenueRecognizedIncreaseInContractAssets
51712000
CY2022 RAASY Revenue Recognized Increase In Contract Assets
RevenueRecognizedIncreaseInContractAssets
50825000
CY2020 us-gaap Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
38164000
CY2021 us-gaap Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
45065000
CY2022 us-gaap Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
19403000
CY2020Q4 us-gaap Contract With Customer Asset Gross Current
ContractWithCustomerAssetGrossCurrent
25075000
CY2021Q4 us-gaap Contract With Customer Asset Gross Current
ContractWithCustomerAssetGrossCurrent
31722000
CY2022Q4 us-gaap Contract With Customer Asset Gross Current
ContractWithCustomerAssetGrossCurrent
63144000
CY2020Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss Current
ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent
6733000
CY2021Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss Current
ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent
10604000
CY2022Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss Current
ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent
12306000
CY2020Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
18342000
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
21118000
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
50838000
CY2019Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss Current
ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent
995000
CY2020Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss Current
ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent
6733000
CY2021Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss Current
ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent
10604000
CY2020 us-gaap Contract With Customer Asset Credit Loss Expense
ContractWithCustomerAssetCreditLossExpense
5738000
CY2021 us-gaap Contract With Customer Asset Credit Loss Expense
ContractWithCustomerAssetCreditLossExpense
3871000
CY2022 us-gaap Contract With Customer Asset Credit Loss Expense
ContractWithCustomerAssetCreditLossExpense
1702000
CY2020Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss Current
ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent
6733000
CY2021Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss Current
ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent
10604000
CY2022Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss Current
ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent
12306000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
121748000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
177376000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
285936000
CY2020 RAASY Revenue Recognized Increase In Contract Liabilities
RevenueRecognizedIncreaseInContractLiabilities
81807000
CY2021 RAASY Revenue Recognized Increase In Contract Liabilities
RevenueRecognizedIncreaseInContractLiabilities
74907000
CY2022 RAASY Revenue Recognized Increase In Contract Liabilities
RevenueRecognizedIncreaseInContractLiabilities
96082000
CY2020 RAASY Revenue Recognized From Cash Received Excluding Amount Recognised As Revenue During Period
RevenueRecognizedFromCashReceivedExcludingAmountRecognisedAsRevenueDuringPeriod
-137435000
CY2021 RAASY Revenue Recognized From Cash Received Excluding Amount Recognised As Revenue During Period
RevenueRecognizedFromCashReceivedExcludingAmountRecognisedAsRevenueDuringPeriod
-183467000
CY2022 RAASY Revenue Recognized From Cash Received Excluding Amount Recognised As Revenue During Period
RevenueRecognizedFromCashReceivedExcludingAmountRecognisedAsRevenueDuringPeriod
-169947000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
177376000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
285936000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
359801000
CY2020 RAASY Revenue Recognized Increase In Contract Liabilities
RevenueRecognizedIncreaseInContractLiabilities
81807000
CY2021 RAASY Revenue Recognized Increase In Contract Liabilities
RevenueRecognizedIncreaseInContractLiabilities
74907000
CY2022 RAASY Revenue Recognized Increase In Contract Liabilities
RevenueRecognizedIncreaseInContractLiabilities
96082000
CY2022Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
12000000 usd
CY2022Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
83575000
CY2022Q4 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
14945000
CY2022Q4 RAASY Purchase Obligation Due In Second Year And Due After Second Year
PurchaseObligationDueInSecondYearAndDueAfterSecondYear
1736000
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
105000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
794000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
780000

Files In Submission

Name View Source Status
0001493152-24-033941-index-headers.html Edgar Link pending
0001493152-24-033941-index.html Edgar Link pending
0001493152-24-033941.txt Edgar Link pending
0001493152-24-033941-xbrl.zip Edgar Link pending
chart_001.jpg Edgar Link pending
ex11-2.htm Edgar Link pending
ex12-1.htm Edgar Link pending
ex12-2.htm Edgar Link pending
ex13-1.htm Edgar Link pending
ex13-2.htm Edgar Link pending
ex15-1.htm Edgar Link pending
ex15-1_001.jpg Edgar Link pending
ex15-1_002.jpg Edgar Link pending
ex15-2.htm Edgar Link pending
ex15-2_001.jpg Edgar Link pending
ex15-3.htm Edgar Link pending
ex15-3_001.jpg Edgar Link pending
ex15-3_002.jpg Edgar Link pending
ex2-6.htm Edgar Link pending
ex8-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form20-f.htm Edgar Link pending
form20-f_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R111.htm Edgar Link pending
R112.htm Edgar Link pending
R113.htm Edgar Link pending
R114.htm Edgar Link pending
R115.htm Edgar Link pending
R116.htm Edgar Link pending
R117.htm Edgar Link pending
R118.htm Edgar Link pending
R119.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
form20-f_htm.xml Edgar Link completed
R12.htm Edgar Link pending
R120.htm Edgar Link pending
R121.htm Edgar Link pending
R122.htm Edgar Link pending
R123.htm Edgar Link pending
R124.htm Edgar Link pending
R125.htm Edgar Link pending
R126.htm Edgar Link pending
R127.htm Edgar Link pending
R128.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
raasy-20221231.xsd Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
raasy-20221231_cal.xml Edgar Link unprocessable
raasy-20221231_lab.xml Edgar Link unprocessable
raasy-20221231_def.xml Edgar Link unprocessable
raasy-20221231_pre.xml Edgar Link unprocessable